Multisystem Inflammatory Syndrome in Children: Examining Emerging Data and Identifying Key Knowledge Gaps.
Pediatr Emerg Care
; 38(2): 83-91, 2022 Feb 01.
Article
in English
| MEDLINE | ID: covidwho-1662152
ABSTRACT
ABSTRACT Multisystem inflammatory syndrome in children (MIS-C) is a syndrome of abnormal immune response after severe acute respiratory syndrome coronavirus 2 infection that can result in organ dysfunction including severe cardiovascular compromise in children. Increased evidence supports a clinical and laboratory profile in MIS-C distinct from Kawasaki disease, with MIS-C typically occurring in older children and with more prominent gastrointestinal and neurologic symptoms, as well as increased inflammation, lymphopenia, and cardiac injury on laboratory testing. However, high-level evidence regarding best practices for treatment and long-term outcomes in MIS-C is limited.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Connective Tissue Diseases
/
COVID-19
Type of study:
Prognostic study
Topics:
Long Covid
Limits:
Child
/
Humans
Language:
English
Journal:
Pediatr Emerg Care
Journal subject:
Emergency Medicine
/
Pediatrics
Year:
2022
Document Type:
Article
Affiliation country:
Pec.0000000000002633
Similar
MEDLINE
...
LILACS
LIS